MEDICO Stock Overview
Develops, manufactures, and sells pharmaceutical and nutraceutical products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medico Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹46.26 |
| 52 Week High | ₹92.95 |
| 52 Week Low | ₹34.80 |
| Beta | 0.16 |
| 11 Month Change | -6.20% |
| 3 Month Change | 2.98% |
| 1 Year Change | -40.73% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 91.16% |
Recent News & Updates
Recent updates
Investors Appear Satisfied With Medico Remedies Limited's (NSE:MEDICO) Prospects As Shares Rocket 27%
Nov 12
Medico Remedies Limited's (NSE:MEDICO) P/E Is Still On The Mark Following 25% Share Price Bounce
Sep 21Medico Remedies Limited (NSE:MEDICO) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
Mar 22Here's Why We Think Medico Remedies (NSE:MEDICO) Is Well Worth Watching
Jun 22What You Can Learn From Medico Remedies Limited's (NSE:MEDICO) P/E After Its 27% Share Price Crash
Jun 26Estimating The Fair Value Of Medico Remedies Limited (NSE:MEDICO)
Jun 03Shareholder Returns
| MEDICO | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.4% | 2.3% | 2.4% |
| 1Y | -40.7% | 43.8% | 29.5% |
Return vs Industry: MEDICO underperformed the Indian Pharmaceuticals industry which returned 43.8% over the past year.
Return vs Market: MEDICO underperformed the Indian Market which returned 29.5% over the past year.
Price Volatility
| MEDICO volatility | |
|---|---|
| MEDICO Average Weekly Movement | 7.5% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: MEDICO has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: MEDICO's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 193 | Harshit Mehta | medicoremedies.com |
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It exports its products.
Medico Remedies Limited Fundamentals Summary
| MEDICO fundamental statistics | |
|---|---|
| Market cap | ₹3.85b |
| Earnings (TTM) | ₹76.77m |
| Revenue (TTM) | ₹1.41b |
50.1x
P/E Ratio2.7x
P/S RatioIs MEDICO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDICO income statement (TTM) | |
|---|---|
| Revenue | ₹1.41b |
| Cost of Revenue | ₹1.06b |
| Gross Profit | ₹356.59m |
| Other Expenses | ₹279.82m |
| Earnings | ₹76.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 25.25% |
| Net Profit Margin | 5.44% |
| Debt/Equity Ratio | 18.6% |
How did MEDICO perform over the long term?
See historical performance and comparison